🚨 ~30% of people with Type 1 Diabetes develop chronic kidney disease.
On Sept 17, 2026, the FDA approved Bayer's finerenone (Kerendia®) for CKD in adults with T1D — the first new treatment for this group in 30+ years.
Follow for more diabetes research updates 🧵👇
